COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02293837
Recruitment Status : Active, not recruiting
First Posted : November 18, 2014
Last Update Posted : February 5, 2020
Immune Tolerance Network (ITN)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 10, 2019
Estimated Study Completion Date : August 2020
Certification/Extension First Submitted : January 22, 2020